Dynavax Technologies (DVAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2003 | 12-2002 | 12-2001 | |
| Cash Flows From Operating Activities | |||
| Net Income | -4,718 | -18,030 | -18,412 |
| Depreciation Amortization | 353 | 670 | 636 |
| Accounts receivable | N/A | N/A | -902 |
| Accounts payable and accrued liabilities | -866 | N/A | -403 |
| Other Working Capital | -940 | 1,250 | 2,149 |
| Other Operating Activity | 1,180 | 2,120 | 3,320 |
| Operating Cash Flow | $-4,991 | $-13,990 | $-13,612 |
| Cash Flows From Investing Activities | |||
| Change In Deposits | 6,481 | N/A | 15,598 |
| PPE Investments | -22 | -460 | -1,084 |
| Other Investing Activity | 0 | -17,130 | 0 |
| Investing Cash Flow | $6,459 | $-17,590 | $14,514 |
| Cash Flows From Financing Activities | |||
| Debt Repayment | 35 | N/A | -152 |
| Common Stock Issued | N/A | N/A | 3 |
| Common Stock Repurchased | -36 | N/A | -5 |
| Other Financing Activity | 0 | 32,410 | -7 |
| Financing Cash Flow | $-1 | $32,410 | $-161 |
| Beginning Cash Position | 5,171 | 4,340 | 3,606 |
| End Cash Position | 6,638 | 5,170 | 4,347 |
| Net Cash Flow | $1,467 | $820 | $741 |
| Free Cash Flow | |||
| Operating Cash Flow | -4,991 | -13,990 | -13,612 |
| Capital Expenditure | -22 | N/A | -1,084 |
| Free Cash Flow | -5,013 | -13,990 | -14,696 |